Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Neurogastroenterol Motil. 2009 Sep 7;22(2):186–e64. doi: 10.1111/j.1365-2982.2009.01406.x

Figure 4. SERCA2 and PLB expression is decreased in distal colon smooth muscles from DSS-treated mice.

Figure 4

Representative western blots of SERCA2 (A), and PLB (C) in distal colon smooth muscles SR fractions from control (Con) and DSS-treated mice on days 1-5 post-DSS-treatment. Each lane contains 50 μg of protein. Lower panels are immunoblots of smooth muscle myosin heavy chain (5μg protein per lane). Densitometry of SERCA2 (B), and PLB (D) western blots from control (Con) and DSS-treated mice at days 1-5 post-DSS treatment. Control intensity values from the densitometry analyses were normalized to 1. (n=5 western blots from 5 different sets of control and DSS-treated mice, *P < 0.05 compared to control).